Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 46Burkitt Lymphoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Recurrence 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Smoldering Multiple Myeloma 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Lung Neoplasms 2Leukemia 2Down Syndrome 2beta-Thalassemia 1Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thalassemia 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Plasmacytoma 1Plasmablastic Lymphoma 1Oropharyngeal Neoplasms 1

Interventions

Oxaliplatin 9Leucovorin 8Fluorouracil 8Bevacizumab 6Cetuximab 5Specimen Handling 4fludarabine 3Pemetrexed 3Nivolumab 3Magnetic Resonance Spectroscopy 3Cyclophosphamide 3pembrolizumab 2encorafenib 2dehydroftorafur 2aldesleukin 2Laparoscopy 2Irinotecan 2Immunoglobulin G 2Gemcitabine 2Folfox protocol 2Disulfides 2Conversion to Open Surgery 2Cisplatin 2Celecoxib 2Carboplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Dexamethasone × 30 days × Clear all
NCT00492999 2026-06-03

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
64 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡